Development Forum (74 results)

Condition: Good. Item in good condition. Textbooks may not include supplemental items i.e. CDs, access codes etc.

Condition: Very Good. Pages intact with possible writing/highlighting. Binding strong with minor wear. Dust jackets/supplements may not be included. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good.

Condition: Very Good. Pages intact with possible writing/highlighting. Binding strong with minor wear. Dust jackets/supplements may not be included. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good.

paperback. Condition: Very Good.

paperback. Condition: Very Good. Clean, unmarked copy.

Soft cover. Condition: Very Good.

paperback. Condition: Very Good.

Wraps. Condition: Fine. 61 pages. On human and citizenship rights of women, e.g., inheritance rights, rights to education and employment, reproductive health, trafficing of women and girls, etc.

Paperback. Condition: Good. Satisfaction 100% guaranteed.

paperback. Condition: Very Good.

paperback. Condition: Fine.

paperback. Condition: Very Good. Connecting readers with great books since 1972! Used books may not include companion materials, and may have some shelf wear or limited writing. We ship orders daily and Customer Service is our top priority.

paperback. Condition: Very Good.

PAP. Condition: New. New Book. Shipped from UK. Established seller since 2000.

Broschur. Condition: Befriedigend. 125 Seiten exBibliotheksexemplar mit den üblichen Stempeln/Signaturen, Kanten etwas berieben / bestossen, Knicke /// Standort Wimregal HFT-70.143 ISBN 9789264142497 WITHIN THE EU: shipping only to GERMANY and AUSTRIA due to the new EPR regulations. Sprache: Englisch Gewicht in Gramm: 187. …

Condition: good. A copy that has been read, remains in good condition. All pages are intact, and the cover is intact. The spine and cover show signs of wear. Pages can include notes and highlighting and show signs of wear, and the copy can include "From the library of" labels or previous owner inscriptions. 100% GUARANTEE! Shipped with delivery confirmation, if you're not satisfied with purchase please return item! Ships via media mail.…

Soft cover. Condition: Very Good. 42 pages. Illustrated. (BT#18).

Soft cover. Condition: Very Good. 324 pages. Mohammed Bin Jassim Saqir "The Arab World Challenge.And The Future" / Shahid Hasan Siddiqui "Instruments of Islamic Banking in Operations" / Samy Nathan Garas "Internationalization of Islamic Financial Institutions: Challenges and Paths to Solution" / Hussain Shaban "International Terrorism and Human Rights: An Arab Vision" / AbdulNabi Alekry "'Forum for the future 2007 - Partnership for Development and Progress' Sub-ministerial meeting in Berlin" (SL#24). …

Condition: New. In.

PAP. Condition: New. New Book. Shipped from UK. Established seller since 2000.

Paperback. Condition: New. Whether or not the United States has safe and effective medical countermeasures--such as vaccines, drugs, and diagnostic tools--available for use during a disaster can mean the difference between life and death for many Americans. The Food and Drug Administration (FDA) and the scientific community at large could benefit from improved scientific tools and analytic techniques to undertake the complex scientific evaluation and decision making needed to make essential medical countermeasures available. At the request of FDA, the Institute of Medicine (IOM) held a workshop to examine methods to improve the development, evaluation, approval, and regulation of medical countermeasures. During public health emergencies such as influenza or chemical, biological, radiological/nuclear (CBRN) attacks, safe and effective vaccines, treatments, and other medical countermeasures are essential to protecting national security and the well being of the public. Advancing Regulatory Science for Medical Countermeasure Development examines current medical countermeasures, and investigates the future of research and development in this area.Convened on March 29-30, 2011, this workshop identified regulatory science tools and methods that are available or under development, as well as major gaps in currently available regulatory science tools. Advancing Regulatory Science for Medical Countermeasure Development is a valuable resource for federal agencies including the Food and Drug Administration (FDA), the Department of Health and Human Services (HHS), the Department of Defense (DoD), as well as health professionals, and public and private health organizations.…

PAP. Condition: New. New Book. Shipped from UK. Established seller since 2000.

Condition: New. Editor(s): Claiborne, Anne B.; Olson, Steve. Num Pages: 118 pages, Illustrations. Category: (P) Professional & Vocational. Dimension: 229 x 152 x 0. . . 2012. Paperback. . . . . Books ship from the US and Ireland.

Paperback / softback. Condition: New. New copy - Usually dispatched within 3 working days.

Condition: New. Editor(s): Claiborne, Anne B.; Olson, Steve. Num Pages: 118 pages, Illustrations. Category: (P) Professional & Vocational. Dimension: 229 x 152 x 0. . . 2012. Paperback. . . . .

Condition: As New. Unread book in perfect condition.

Condition: New. In.

Condition: New.

Paperback. Condition: new. Paperback. To effectively treat patients diagnosed with drug-resistant (DR) tuberculosis (TB) and protect the population from further transmission of this infectious disease, an uninterrupted supply of quality-assured (QA), second-line anti-TB drugs (SLDs) is necessary. Patients diagnosed with multidrug-resistant tuberculosis (MDR TB)-a disease caused by strains of Mycobacterium tuberculosis (M.tb.) resistant to two primary TB drugs (isoniazid and rifampicin)-face lengthy treatment regimens of 2 years or more with daily, directly observed treatment (DOT) with SLDs that are less potent, more toxic, and more expensive than those used to treat drug-susceptible TB. From 2000 to 2009, only 0.2-0.5 percent of the estimated 5 million MDR TB cases globally were treated with drugs of known quality and in programs capable of delivering appropriate care (Keshavjee, 2012). The vast majority of MDR TB patients either died from lack of treatment or contributed to the spread of MDR TB in their communities. A strengthened global supply chain for SLDs could save lives by consistently delivering high quality medicines to more of the people who need them.This public workshop explored innovative solutions to the problem of how to get the right SLDs for MDR TB to people who critically need them. More specifically, the workshop examined current problems and potential opportunities for coordinated international efforts to ensure that a reliable and affordable supply of high-quality SLDs is available. Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant Tuberculosis: Workshop Summary covers the objectives of the workshop, which were to review: -To what extent and in what ways current mechanisms are or are not effectively accomplishing what is needed, including consideration of bottlenecks. -The advantages and disadvantages of centralization in the management of the global drug supply chain, and potential decentralized approaches to improve operations of the supply chain. -What can be learned from case studies and examples from other diseases (e.g., the Affordable Medicines Facility-malaria (AMFm) and the U.S.President's Emergency Plan for AIDS Relief [PEPFAR]) - The current allocation of responsibilities and roles of the private (including industry and nonprofit public health organizations) and public sectors, and examination of opportunities for enhancing and optimizing collaboration -Identification of potential innovative solutions to the problem "Forum on drug discovery, development, and translation."--Cover. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. …

Paperback. Condition: Brand New. 1st edition. 195 pages. 9.00x6.00x0.75 inches. In Stock.